Purple Biotech Ltd. (PPBT) stock

PPBTNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 19, 2026Score 1/30

$1.56+0.07 (+4.70%)

Close on Nov 12, 2026Market cap $1.45MP/E 0.0Yield –

Purple Biotech operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2020 it was -1261.2%, against -715.6% the year before.

Period	Period end	Value	Change (pts)
FY2020	Dec 31, 2020	-1261.2%	−545.6
FY2019	Dec 31, 2019	-715.6%	+67.0
FY2018	Dec 31, 2018	-782.6%	+11183.4
FY2017	Dec 31, 2017	-11966.0%	–

See a number that looks wrong?